Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases.
The use of recombinant proteins has been an invaluable tool for the study of the structure and function of cell components, and the analysis of autoimmune-mediated responses. Furthermore, it has also been instrumental in facilitating the development of reliable assays for the detection of a number of autoantibodies. This article discusses basic aspects of recombinant DNA technology, as well as its applications and limitations in the diagnosis of autoimmune connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic scleroderma, mixed connective tissue disease, autoimmune inflammatory myopathies and primary vasculitides.
Galperin
C
C
Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, School of Medicine, 95616, USA.
Coppel
R L
RL
Gershwin
M E
ME
D001323:Autoantibodies / Q000032:analysis; D001324:Autoantigens; D001327:Autoimmune Diseases / Q000175:diagnosis*; D015551:Autoimmunity; D003240:Connective Tissue Diseases / Q000175:diagnosis*; D006801:Humans; D011994:Recombinant Proteins
D001323:Autoantibodies; D001324:Autoantigens; D011994:Recombinant Proteins